-
-
-
-
-
-
-
Novus Therapeutics (NVUS) Announces Acquisition of Anelixis Therapeutics in Stock-for-Stock Deal
-
-
-
-
-
-
-
Novus Therapeutics Reports Second Quarter 2018 Financial Results
-
-
-
-
-
-
-
Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
1,158,053 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

